Advertisement

Topics

University of Michigan and AstraZeneca partner to improve treatment for CKD patients

16:45 EST 10 Nov 2017 | News-Medical.net

Patients with Chronic Kidney Disease (CKD) may benefit from a new collaboration between the University of Michigan and AstraZeneca who have partnered to develop a new therapeutic strategy for treatment.

Original Article: University of Michigan and AstraZeneca partner to improve treatment for CKD patients

NEXT ARTICLE

More From BioPortfolio on "University of Michigan and AstraZeneca partner to improve treatment for CKD patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...